Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: Comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings

Oncology (Switzerland)

Volumn 50, Issue 6, 1993, Pages 426-429

  Nishioka, Hiroto ^a   Hiasa, Yoshio ^a   Hayashi, Isao ^a   Kitahori, Yoshiteru ^a   Konishi, Noboru ^a   Sugimura, Masdhito ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Clinicopathological findings; Oral squamous cell carcinoma; P53 oncoprotein; Proliferating cell nuclear antigen

Indexed keywords

CYCLINE; MONOCLONAL ANTIBODY; ONCOPROTEIN; PROTEIN P53;

ARTICLE; CANCER STAGING; COMPARATIVE STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SQUAMOUS CELL CARCINOMA;

ANTIGENS, NEOPLASM; BIOPSY; CARCINOMA, SQUAMOUS CELL; COMPARATIVE STUDY; FEMALE; GINGIVAL NEOPLASMS; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA, ORAL; LIP NEOPLASMS; MALE; MOUTH NEOPLASMS; NUCLEAR PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN P53; TONGUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0027367016     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227223     Document Type: Article

References (14)

1. Finlay CA. Hinds PW. Levine AJ: The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989:57:1083-1093.
2. Chen PW. Chen Y. Bookstein R. Lee WH: Ge-nclic mechanisms of tumor suppression by the human p53 gene. Science 1990:250:1576-1580.
3. Baker SJ. Markowitz S. Fearon ER. Willson JKV. Vogeistein B: Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990:249:912-915.
4. Miyaki M. Seki M. Okamoto M. el at: Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis. Cancer Res 1990: 50:7166-7173.
5. Mazars R. Pujol P. Maudelonde T. Jeanteur P. Theillet C: p53 mutations in ovarian cancer. A late event? Oncogene 1991:6:1685-1690.
6. Osborne RJ. Merlo GR. Mitsudomi T. Venesio T. Liscia DS. Cappa APM. Chiba I. Takahashi T: Mutations in the p53 gene in human breast cancers. Cancer Res 1991:51:6194-6198.
7. Sakai E. Tsuchida N: Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene 1992:7:927-933.
8. Oren M. Maltzman W. Levine AJ: Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol Cell Biol 1984:1:101-110.
9. Garcia RL. Coltrera MD. Gown AM: Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Am J Pathol 1989:134:733-739.
10. Willen R. Nathanson A. Moberger G. Anncroth G: Squamous cell carcinoma of the gingiva. Histological classification and grading of malignancy. Acta Otolaryngol 1975: 79:146-154.
11. TNM classification of malignant tumours, ed 4. International Union Against Cancer. Geneva. 1987. pp 13-29.
12. Bennett WP. Hollstein MC. He A. Zhu SM. Reasu JH. Trump BK. Metcalf RA. Welsh JA. Midgley C. Lane DP. Harris CC: Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. Oncogene 1991:6:1779-1784.
13. Tamura G. Maesawa C. Suzuki Y. Satodatc R. Ishida K. Saito K: p53 gene mutations in esophageal cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis. Jpn J Cancer Res 1992:83:559-562.
14. Mitsudomi T, Steinberg SM, Nau MM, Carbonc D, D'Amico D, Bodner S, Oie HK, Linnoila RL, Mulshine JL, Minna JD, Gazdar AF:p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 1992:7:171-180.